Nemes Rush Group LLC Astrazeneca PLC Transaction History
Nemes Rush Group LLC
- $809 Billion
- Q4 2024
A detailed history of Nemes Rush Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nemes Rush Group LLC holds 132 shares of AZN stock, worth $9,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
132
Previous 100
32.0%
Holding current value
$9,712
Previous $6.78 Million
27.28%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...